Legend Biotech to Host Investor Conference Call on Second-Quarter Results
03 Agosto 2023 - 7:30AM
Business Wire
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a
global biotechnology company developing, manufacturing and
commercializing novel therapies to treat life-threatening diseases,
will host a conference call for investors at 8:00am Eastern Time on
Tuesday, August 15, 2023 to review second-quarter results. Company
executives will provide an overview of Legend Biotech’s performance
for the quarter.
Investors and other interested parties may join the live audio
webcast of the call via this weblink.
A replay of the webcast and the earnings news release will be
available at Legend Biotech’s website at
https://investors.legendbiotech.com/events-and-presentations
approximately two hours after the call concludes.
About Legend Biotech Legend Biotech is a global
biotechnology company dedicated to treating, and one day curing,
life-threatening diseases. Headquartered in Somerset, New Jersey,
we are developing advanced cell therapies across a diverse array of
technology platforms, including autologous and allogeneic chimeric
antigen receptor T-cell, gamma-delta T cell and natural killer (NK)
cell-based immunotherapy. From our three R&D sites around the
world, we apply these innovative technologies to pursue the
discovery of cutting-edge therapeutics for patients worldwide.
Learn more at https://legendbiotech.com/ and follow us on
Twitter and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230803417761/en/
Press: Tina Carter, Corporate Communications Lead, Legend
Biotech tina.carter@legendbiotech.com (908) 331-5025
Investor: Jessie Yeung, Head of Investor Relations and
Public Relations, Legend Biotech jessie.yeung@legendbiotech.com
Legend Biotech (NASDAQ:LEGN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Legend Biotech (NASDAQ:LEGN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024